A mathematical model for interpreting in vitro rhGH release from laminar implants

Altinkaya, 2004, Membrane formation by dry-cast process model validation through morphological studies, J. Mem. Sci., 249, 163, 10.1016/j.memsci.2004.10.008 Bodmeier, 1989, Evaluation of biodegradable poly(lactide) pellets prepared by direct compression, J. Pharm. Sci., 10, 819, 10.1002/jps.2600781008 Cardinal, 2000, Controlled release osmotic drug delivery systems for oral applications, 411 Cussler, 1984, Fundamentals of mass transfer, 215 Dorta, 1993, Effects of polymerization variables on PLGA properties: molecular weight, composition and chain structure, Int. J. Pharm., 100, 9, 10.1016/0378-5173(93)90069-R Dorta, 2002, Potential applications of PLGA-film-implants in modulating in vitro drugs release, Int. J. Pharm., 6, 149, 10.1016/S0378-5173(02)00431-3 García, 2002, Biodegradable laminar implants for sustained release of recombinant human growth hormone, Biomaterials, 23, 4759, 10.1016/S0142-9612(02)00225-9 Gilding, 1979, Biodegradable polymers for use in surgery polyglycolic/polylactic homo and copolymers, Polymer, 20, 1459, 10.1016/0032-3861(79)90009-0 Glynn, 1976, A general model for prediction of molecular weight distributions of degraded polymers: development and comparison with ultrasonic degradation experiments, J. Macromol. Sci. Chem., A6, 1653 Gould, 1994, Fifty poly(d,l glycolic acid-lactic acid) copolymer as a drug delivery system for 5-Fluorouracil: a histopathological valuation, Can. J. Ophthalmol., 29, 168 Hashizoe, 1994, Scleral plug of biodegradable polymers for controlled drug release in the vitreous, Arch. Ophthalmol., 112, 1380, 10.1001/archopht.1994.01090220130035 Heller, 1980, Controlled release of biologically active compounds from bioerodible polymers, Biomaterials, 1, 51, 10.1016/0142-9612(80)90060-5 Huang, 2001, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems, J. Control. Release, 73, 121, 10.1016/S0168-3659(01)00248-6 International Conference of Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Methodology (ICH-Q2B), 1996. Jain, 1998, Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches, Drug Dev. Ind. Pharm., 24, 703, 10.3109/03639049809082719 Katayama, 1984, Reentrant phase transition in acrylamide-derivative copolymer gels, Macromolecules, 17, 2641, 10.1021/ma00142a032 Kim, 2004, Comparative study on sustained release of human growth hormone form semi-crystalline poly(l-lactic acid) and amorphous poly(d,l-lactic-co-glycolic acid) microspheres: morphological effect on protein release, J. Control. Release, 98, 115, 10.1016/j.jconrel.2004.04.020 Kou, 2000, Transport in polymer systems, 445 Kunou, 2000, Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis, J. Control. Release, 68, 263, 10.1016/S0168-3659(00)00267-4 Lemaire, 2003, Structural modelling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process, Int. J. Pharm., 258, 95, 10.1016/S0378-5173(03)00165-0 Santoveña, 2004, Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release, Biomaterials, 25, 925, 10.1016/S0142-9612(03)00592-1 Santoveña, A., Álvarez-Lorenzo, C., Concheiro, A., Llabrés, M., Fariña, J.B., in press. Structural properties of biodegradable polyesters and rheological behaviour of their dispersions and films. J. Biomater. Sci. Polymer Ed. Shah, 1992, Poly(glycolic acid co-d,l-lactic acid): diffusion of degradation controlled drug delivery?, J. Control. Release, 18, 261, 10.1016/0168-3659(92)90171-M Takada, 2003, A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations, J. Pharm. Pharmacol., 55, 951, 10.1211/0022357021323 Takada, 2003, Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique, J. Control. Release, 88, 229, 10.1016/S0168-3659(02)00494-7 Vogelhuber, 2001, Programmable biodegradable implants, J. Control. Release, 73, 75, 10.1016/S0168-3659(01)00282-6 Wang, 1996, In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjuntival implant based on poly(d,l-lactide-co-glycolide), Pharm. Res., 13, 1059, 10.1023/A:1016062825360 Zilberman, 2001, Structured drug-loaded bioresorbable films for support structures, J. Biomater. Sci. Polymer Ed., 0, 1